172 related articles for article (PubMed ID: 37171576)
21. Naphthoquinone-Dopamine Hybrids Inhibit α-Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate-Induced Toxicity.
Paul A; Huber A; Rand D; Gosselet F; Cooper I; Gazit E; Segal D
Chemistry; 2020 Dec; 26(69):16486-16496. PubMed ID: 32870550
[TBL] [Abstract][Full Text] [Related]
22. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
23. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
24. Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an
Kim BJ; Noh HR; Jeon H; Park SM
Exp Neurobiol; 2023 Jun; 32(3):147-156. PubMed ID: 37403223
[TBL] [Abstract][Full Text] [Related]
25. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
26. An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.
Javed H; Kamal MA; Ojha S
CNS Neurol Disord Drug Targets; 2016; 15(10):1240-1252. PubMed ID: 27658511
[TBL] [Abstract][Full Text] [Related]
27. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
28. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M
Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233
[TBL] [Abstract][Full Text] [Related]
29. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.
Mazzulli JR; Mishizen AJ; Giasson BI; Lynch DR; Thomas SA; Nakashima A; Nagatsu T; Ota A; Ischiropoulos H
J Neurosci; 2006 Sep; 26(39):10068-78. PubMed ID: 17005870
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
31. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease.
Kam TI; Mao X; Park H; Chou SC; Karuppagounder SS; Umanah GE; Yun SP; Brahmachari S; Panicker N; Chen R; Andrabi SA; Qi C; Poirier GG; Pletnikova O; Troncoso JC; Bekris LM; Leverenz JB; Pantelyat A; Ko HS; Rosenthal LS; Dawson TM; Dawson VL
Science; 2018 Nov; 362(6414):. PubMed ID: 30385548
[TBL] [Abstract][Full Text] [Related]
32. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia.
Dai M; Yan L; Yu H; Chen C; Xie Y
J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922
[TBL] [Abstract][Full Text] [Related]
33. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
[TBL] [Abstract][Full Text] [Related]
34. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein A53T Binds to Transcriptional Adapter 2-Alpha and Blocks Histone H3 Acetylation.
Lee JY; Kim H; Jo A; Khang R; Park CH; Park SJ; Kwag E; Shin JH
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065515
[TBL] [Abstract][Full Text] [Related]
36. Ca
Ueda J; Uemura N; Ishimoto T; Taguchi T; Sawamura M; Nakanishi E; Ikuno M; Matsuzawa S; Yamakado H; Takahashi R
Mov Disord; 2023 Jun; 38(6):1056-1067. PubMed ID: 37066491
[TBL] [Abstract][Full Text] [Related]
37. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
[TBL] [Abstract][Full Text] [Related]
38. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
39. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
[TBL] [Abstract][Full Text] [Related]
40. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]